We Help Guide You in Your Cancer Battle — From Diagnosis Through Survivorship.

Our compassionate and supportive team at Houston Methodist Cancer Center at St. John offers high quality services — screenings, diagnostics, genetic testing, advanced technology, clinical trials and patient support — in the Greater Bay Area.

Our experts, including breast radiologists, oncologists and surgeons, routinely collaborate to ensure patients receive the best possible care near their homes. Dedicated rehabilitation and nutritional specialists, as well as our patient navigator, will accompany you through survivorship, ensuring you and your family receive the care, support and resources you need.

We offer the latest chemotherapy treatments and targeted radiation therapies. Our doctors have access to cancer high-risk programs designed to help patients prevent the disease with nutrition, education, genetic counseling and disease surveillance.

Additionally, we are committed to cancer prevention by offering community screenings and educational events.
 

Cancers Treated at Houston Methodist Cancer Center at St John:

Brain 
Breast 
Cervical
Colorectal
Esophageal
Head & Neck
Kidney
Leukemia
Liver
Lung
Lymphoma 
Ovarian
Pancreatic
Prostate
Skin
Stomach
Testicular
Thyroid
Uterine
Vulvar and Vaginal Cancer

See a complete list of cancers treated at all of our hospitals.

We offer a wide variety of treatment options including surgerysystemic therapies, and innovative radiation therapies.
Diagnosis & Treatment Options
Diagnosis and Treatment

We are dedicated to offering the most advanced cancer treatments available. We believe in a proactive and preventive approach that includes understanding risk factors and engaging in proper screening. If we do find cancer, we are here to guide you through every step of your journey. 

Clinical Trials
Clinical Trials

Our approach to cancer research revolves around a team of physicians, research scientists, staff and pharmacists. Qualified patients can participate in clinical trials that include access to novel medications and options unavailable outside of the research setting.